King's Lynn hospital recognised for digital innovations
Lynn's Queen Elizabeth Hospital has been awarded the Imprivata Return on Investment award for its implementation of electronic prescribing and medicines administration and single sign-on.
The digital solution provides a safer method of prescribing along with ease of access and witnessing via single sign-on, which reduces login and authentication delays for clinical teams and provides a better overall patient and staff experience.
The QEH was credited by Imprivata as one of the quickest and most successful single sign-on developments seen in recent years, and the QEH Trust was applauded for its innovative integration across the hospital, which is nearing completion.
The project’s critical success factor was in leveraging optimised secondary authentication when clinicians were e-charting, e-signing, and e-witnessing patient medication.
Nigel Hall, chief digital and information officer said: "We are absolutely delighted to win this national award. He said: "It is testament to the diligence and hard work of so many members of Team QEH who have worked so well together, with partners, to make this such a success."
"We are extremely proud of how we have applied Imprivata technology to deliver a highly secure medicines management methodology that keeps our patients safe whilst improving the digital experience for staff across the organisation.
"The roll-out of EPMA and single sign-on are critical in our journey of improvement, which includes accelerating the digitisation of our hospital so that we can see the benefits for our patients and staff."
Gruminder Gill, international marketing programs consultant, at Imprivata said: "We are thrilled to present this award to the Queen Elizabeth Hospital King’s Lynn, and applaud the Trust for its innovative integration of the Imprivata ConfirmID and WellSky Electronic Prescribing and Medicines Administration (EPMA) applications in the pharmacy department."
